SMS Pharmaceuticals jumped 5.19% to Rs 92.20 at 15:18 IST on BSE after the company announced that it has increased its investment in VKT Pharma.
The announcement was made after market hours yesterday, 6 April 2017.Meanwhile, the BSE Sensex was down 216.62 points, or 0.72%, to 29,710.72. Meanwhile, the BSE Small-Cap index was down 65.58 points, or 0.44%, to 14,685.39.
On BSE, so far 84,000 shares were traded in the counter, compared with an average volume of 11,669 shares in the past one quarter. The stock hit a high of Rs 93.90 and a low of Rs 88 so far during the day. The stock hit a 52-week high of Rs 115 on 6 October 2016. The stock hit a 52-week low of Rs 78 on 21 November 2016.
The stock had underperformed the market over the past one month till 6 April 2017, rising 0.86% compared with the Sensex's 3.55% rise. The scrip also underperformed the market over the past one quarter, sliding 7.3% as against the Sensex's 11.84% advance.
The small-cap company has an equity capital of Rs 8.47 crore. Face value per share is Re 1.
SMS Pharmaceuticals said that the company has further invested Rs 2.7 crore by subscribing 1.20 lakh equity shares at Rs 225 per share. After the present acquisition, the total holding of the company in VKT Pharma stood at 41.08%, SMS Pharmaceuticals said.
Net profit of SMS Pharmaceuticals rose 18.33% to Rs 13.04 crore on 16.82% rise in net sales to Rs 167.98 crore in Q3 December 2016 over Q3 December 2015.
More From This Section
SMS Pharmaceuticals is a global player in active pharmaceutical ingredient (API) manufacturing.
Powered by Capital Market - Live News